Back to User profile » Dr David Sclar
Papers published by Dr David Sclar:
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
Peckham AM, Ananickal MJ, Sclar DA
Risk Management and Healthcare Policy 2018, 11:109-116
Published Date: 17 August 2018
Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits
Molina KC, Fairman KA, Sclar DA
Drug, Healthcare and Patient Safety 2018, 10:37-43
Published Date: 3 May 2018
Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson’s disease: a national assessment of US office-based physician visits
Early NK, Peckham AM, Fairman KA, Sclar DA
Journal of Parkinsonism and Restless Legs Syndrome 2017, 7:79-84
Published Date: 16 November 2017
Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice
Fairman KA, Davis LE, Sclar DA
Therapeutics and Clinical Risk Management 2017, 13:957-965
Published Date: 3 August 2017